Literature DB >> 19169615

CD38 in bovine lung: A multicatalytic NADase.

Valeria Polzonetti1, Stefania Pucciarelli, Alberto Vita, Silvia Vincenzetti, Paolo Natalini.   

Abstract

We report the kinetics and molecular properties of CD38 purified from bovine lung microsomal membranes after its solubilization with Triton X-100. The enzyme was found to be a novel member of a multicatalytic NAD(+)-glycohydrolase (NADase, EC 3.2.2.6). It was able to utilize NAD( + ) in different ways, producing nicotinamide (Nam) and either adenosine diphosphoribose (ADPR, NADase activity) or cyclic ADPR (cADPR, cyclase activity); it also catalyzed the hydrolysis of cADPR to ADPR (cADPR, hydrolase activity). In addition, the enzyme catalyzed the pyridine base exchange reaction with conversion of NAD( + ) into NAD analogues. These data are evidence that CD38 is involved in the regulation of both NAD(+) and calcium-mobilizing agents, the concentration resulting in an essential enzyme that plays a key role in cellular energy and signal-transduction systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169615     DOI: 10.1007/s00232-008-9149-x

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  17 in total

Review 1.  Poly(ADP-ribose). The most elaborate metabolite of NAD+.

Authors:  Alexander Bürkle
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

2.  NAD(P)(+)-glycohydrolase from human spleen: a multicatalytic enzyme.

Authors:  G Orsomando; V Polzonetti; P Natalini
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2000-05       Impact factor: 2.231

3.  Regulation of intracellular levels of NAD: a novel role for CD38.

Authors:  Pinar Aksoy; Thomas A White; Michael Thompson; Eduardo N Chini
Journal:  Biochem Biophys Res Commun       Date:  2006-05-15       Impact factor: 3.575

4.  Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

Authors: 
Journal:  Diabetologia       Date:  2003-02-27       Impact factor: 10.122

Review 5.  ARCON: a novel biology-based approach in radiotherapy.

Authors:  Johannes H A M Kaanders; Johan Bussink; Albert J van der Kogel
Journal:  Lancet Oncol       Date:  2002-12       Impact factor: 41.316

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  New functions of a long-known molecule. Emerging roles of NAD in cellular signaling.

Authors:  M Ziegler
Journal:  Eur J Biochem       Date:  2000-03

8.  Adp-ribosyl cyclase and cyclic ADP-ribose hydrolase act as a redox sensor. a primary role for cyclic ADP-ribose in hypoxic pulmonary vasoconstriction.

Authors:  H L Wilson; M Dipp; J M Thomas; C Lad; A Galione; A M Evans
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

Review 9.  The new life of a centenarian: signalling functions of NAD(P).

Authors:  Felicitas Berger; María H Ramírez-Hernández; Mathias Ziegler
Journal:  Trends Biochem Sci       Date:  2004-03       Impact factor: 13.807

Review 10.  Enzymology of NAD+ homeostasis in man.

Authors:  G Magni; A Amici; M Emanuelli; G Orsomando; N Raffaelli; S Ruggieri
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.